Clinical Efficacy and Safety of an Immune Checkpoint Inhibitor in Combination with Regorafenib Therapy as Second-Line Regimen for Patients with Unresectable Hepatocellular Carcinoma

Li J, Jia Y, Shao C, Li Y, Song J

Therapeutics and Clinical Risk Management 2023, 19:329-339

Published Date: 5 April 2023